FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

30675011000036104: agalsidase beta (AU substance)

Status: current, Primitive. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
173917011000036116 agalsidase beta en Synonym Active Case sensitive Australian Medicines Terminology module
173918011000036115 agalsidase beta (AU substance) en Fully specified name Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
agalsidase beta Is a medicinal substance true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
agalsidase beta has intended active ingredient True agalsidase beta Inferred relationship Some 1
agalsidase beta 5 mg injection, vial has intended active ingredient True agalsidase beta Inferred relationship Some 1232880512
agalsidase beta 5 mg injection, vial has Australian BoSS True agalsidase beta Inferred relationship Some 1232880512
agalsidase beta 35 mg injection, vial has intended active ingredient True agalsidase beta Inferred relationship Some 1208382656
agalsidase beta 35 mg injection, vial has Australian BoSS True agalsidase beta Inferred relationship Some 1208382656
Fabrazyme 5 mg powder for injection, 5 mg vial has intended active ingredient True agalsidase beta Inferred relationship Some 2004832480
Fabrazyme 35 mg powder for injection, 35 mg vial has intended active ingredient True agalsidase beta Inferred relationship Some 1110192928
Fabrazyme 35 mg powder for injection, 35 mg vial has Australian BoSS True agalsidase beta Inferred relationship Some 1110192928
Fabrazyme 5 mg powder for injection, 5 mg vial has Australian BoSS True agalsidase beta Inferred relationship Some 2004832480

This concept is not in any reference sets

Back to Start